“SYNAPSE accelerator”, a great opportunity for investors, specialists and technologists
Panel of Technology-based accelerators, a capacity for basic science graduates
Although technologies in diagnostic laboratories influence more than 70% of medical decisions, only 2% of total health costs are allocated to this field. In the world of value-based healthcare, In vitro diagnostics or IVD, play an important role in patient outcomes. furthermore, technologies in diagnostic laboratories and services have the highest impact on reducing health care costs. Therefore, the main policy of modern health systems is based on budget development and utilization of new laboratory diagnostic services and products.
This is a great opportunity that investors, specialists and technologists should participate in it. This panel aims to consider and explain the challenges and opportunities in this field and will be shared experiences and points that entrepreneurs and researchers should pay more attention to.
